Mérieux Equity Partners SAS

About Mérieux Equity Partners SAS

Mrieux Equity Partners SAS is a prominent European investment firm with a specialized focus on the healthcare sector. Established in 2009 and headquartered in Lyon, France, they have developed a strong expertise in equity investments, targeting Biotech, HealthTech, Medical Devices, and Hospital Services industries. With assets under management of 460 million euros, they leverage a deep understanding of the market to support companies with ambitious growth projects and transformative products or services for health. They manage third-party capital and are AMF-registered, highlighting their reputable and regulated position in the industry. Mrieux Equity Partners pursues investment opportunities through two distinct strategies: Venture Capital and Buyout. Their Venture Capital platform aids in the evolution of innovative medical solutions, supporting investments from seed to late-stage ventures across Europe and the United States. Currently, their OMX Europe Venture Fund has made investments ranging from 4 to 10 million euros in 12 companies. On the other hand, their Buyout strategy is oriented towards profitable, fast-growing companies to support their projects and expansions, with current investments per company ranging from 20 to 80 million euros, and greater amounts with co-investments. Their recent investments and divestments span diverse healthcare areas, demonstrating a commitment to fostering growth and regulatory advancements within the sector. With over 50 investments and a professional team located in both Paris and Lyon, the firm's strategy is aligned with their overarching focus on 'One Health,' integrating human and animal health with environmental considerations.